Additionally, cytokine-based therapies, including immune-stimulating molecules such as IL-2, GM-CSF, and interferon-gamma, are being explored to enhance immune activation and counteract the immunosuppressive tumor microenvironment in EwS [10]. This evidence concerns the gene IFNG and neoplasm.